HK1152965A1 - Haemophilus influenzae antigens and corresponding dna fragments - Google Patents

Haemophilus influenzae antigens and corresponding dna fragments

Info

Publication number
HK1152965A1
HK1152965A1 HK11106917.4A HK11106917A HK1152965A1 HK 1152965 A1 HK1152965 A1 HK 1152965A1 HK 11106917 A HK11106917 A HK 11106917A HK 1152965 A1 HK1152965 A1 HK 1152965A1
Authority
HK
Hong Kong
Prior art keywords
dna fragments
haemophilus influenzae
corresponding dna
influenzae antigens
antigens
Prior art date
Application number
HK11106917.4A
Other languages
English (en)
Inventor
Josee Hamel
France Couture
Bernard R Brodeur
Denis Martin
Catherine Ouellet
Mireille Tremblay
Annie Charbonneau
Catherine Vayssier
Original Assignee
Id Biomedical Corp Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp Quebec filed Critical Id Biomedical Corp Quebec
Publication of HK1152965A1 publication Critical patent/HK1152965A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11106917.4A 2000-10-02 2011-07-05 Haemophilus influenzae antigens and corresponding dna fragments HK1152965A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23671200P 2000-10-02 2000-10-02

Publications (1)

Publication Number Publication Date
HK1152965A1 true HK1152965A1 (en) 2012-03-16

Family

ID=22890628

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11106917.4A HK1152965A1 (en) 2000-10-02 2011-07-05 Haemophilus influenzae antigens and corresponding dna fragments

Country Status (13)

Country Link
US (1) US20040171802A1 (es)
EP (4) EP2088197B8 (es)
JP (3) JP2004509647A (es)
AU (1) AU2002211999A1 (es)
BR (1) BR0114403A (es)
CA (1) CA2424275A1 (es)
CY (2) CY1114614T1 (es)
DK (2) DK2270171T5 (es)
ES (2) ES2588023T3 (es)
HK (1) HK1152965A1 (es)
PT (2) PT2270171E (es)
SI (2) SI2270171T1 (es)
WO (1) WO2002028889A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003258422A1 (en) * 2002-08-22 2004-03-11 Id Biomedical Corporation Polypeptides of nontypeable haemophilus influenzae and corresponding dna fragments
GB0410866D0 (en) 2004-05-14 2004-06-16 Chiron Srl Haemophilius influenzae
ES2310062B1 (es) * 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
EP2548885B1 (en) 2005-08-10 2017-10-18 Arne Forsgren AB Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
MY150105A (en) 2006-01-17 2013-11-29 Forsgren Arne A novel surface exposed haemophilus influenzae protein (protein e; pe)
TW201302779A (zh) 2011-04-13 2013-01-16 Glaxosmithkline Biolog Sa 融合蛋白質及組合疫苗
BR112014026812A8 (pt) * 2012-04-26 2022-10-04 Novartis Ag Antígenos e combinações de antígenos
US10279026B2 (en) 2012-04-26 2019-05-07 Glaxosmithkline Biologicals Sa Antigens and antigen combinations
MX2017015110A (es) 2015-06-05 2018-05-07 Firmenich & Cie Microcapsulas con alta deposicion en superficies.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
EP0821737A4 (en) * 1995-04-21 2005-01-19 Human Genome Sciences Inc NUCLEOTIDE SEQUENCE OF THE GENOME HAEMOPHILUS INFLUENZAE RD, THE FRAGMENTS THEREOF, AND ITS APPLICATIONS
GB9513074D0 (en) * 1995-06-27 1995-08-30 Cortecs Ltd Novel anigen
CA2671261A1 (en) 1997-11-06 1999-05-20 Novartis Vaccines And Diagnostics S.R.L. Neisserial antigens

Also Published As

Publication number Publication date
EP2088197B8 (en) 2016-07-20
ES2588023T3 (es) 2016-10-28
EP2280071A2 (en) 2011-02-02
EP2088197A3 (en) 2011-12-21
CA2424275A1 (en) 2002-04-11
DK2270171T5 (da) 2013-11-18
AU2002211999A1 (en) 2002-04-15
EP2280071A3 (en) 2011-04-27
JP2004509647A (ja) 2004-04-02
CY1114614T1 (el) 2016-10-05
EP1322762A2 (en) 2003-07-02
SI2088197T1 (sl) 2016-11-30
PT2088197T (pt) 2016-08-01
DK2270171T3 (da) 2013-10-14
PT2270171E (pt) 2013-11-05
BR0114403A (pt) 2004-02-17
SI2270171T1 (sl) 2013-12-31
EP2270171A3 (en) 2011-04-27
JP2011231114A (ja) 2011-11-17
EP2088197A2 (en) 2009-08-12
WO2002028889A2 (en) 2002-04-11
CY1117746T1 (el) 2017-05-17
DK2088197T3 (en) 2016-08-01
EP2088197B1 (en) 2016-06-08
WO2002028889A3 (en) 2003-04-10
EP2270171A2 (en) 2011-01-05
ES2435923T3 (es) 2013-12-26
EP2270171B1 (en) 2013-09-04
JP2009149642A (ja) 2009-07-09
US20040171802A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
HK1152965A1 (en) Haemophilus influenzae antigens and corresponding dna fragments
AU4141101A (en) Nucleic acids, proteins, and antibodies
AU4341502A (en) Nod2 nucleic acids and proteins
AU5077101A (en) Nucleic acids, proteins, and antibodies
AU2001248172A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001248171A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001248176A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001296301A8 (en) Nucleic acids, proteins, and antibodies
AU2735002A (en) Nod2 nucleic acids and proteins
EP1293568A4 (en) PROTEIN AND ITS DNA
AU2002221759A1 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
EP1294738A4 (en) NOVEL MOTOR PROTEINS AND METHODS OF USING THE SAME
EG22900A (en) Diagnostic reagents and preparing methods thereof
AU2138601A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
GB0019817D0 (en) Sequence data preparation method and appparatus
AU2002221688A1 (en) Haemophilus influenzae basb206 gene and protein
AU1375501A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU2002315305A1 (en) Haemophilus influenzae antigens
AU2002242549A1 (en) Streptococcus pyogenes antigens and corresponding dna fragments
AU7398400A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU5668500A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001236466A8 (en) Nucleic acids, proteins, and antibodies
AU1375601A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU7398700A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU7398600A (en) Chlamydia antigens and corresponding dna fragments and uses thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181001

Effective date: 20181002